Evidence map›Paper›PMID 37289070›Full record

ArticleMicrobiology spectrum2023

A Saliva-Based Serological and Behavioral Analysis of SARS-CoV-2 Antibody Prevalence in Howard County, Maryland.

Alan C Brown, Phillip T Koshute, Hannah P Cowley, Michael S Robinette, Sarah R Gravelyn, Shraddha V Patel, Eunice Y Ju, Carolyn T Frommer, Alexander E Zambidis, Eric J Schneider and 7 more

Abstract read
In one paragraph

Article in Microbiology spectrum, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Alan C Brown *Johns Hopkins University Applied Physics Laboratory, Laurel, Maryland, USA.
Phillip T Koshute *Johns Hopkins University Applied Physics Laboratory, Laurel, Maryland, USA.
Hannah P CowleyJohns Hopkins University Applied Physics Laboratory, Laurel, Maryland, USA.
Michael S RobinetteJohns Hopkins University Applied Physics Laboratory, Laurel, Maryland, USA.
Sarah R GravelynJohns Hopkins University Applied Physics Laboratory, Laurel, Maryland, USA.
Shraddha V PatelJohns Hopkins University Applied Physics Laboratory, Laurel, Maryland, USA.
Eunice Y JuJohns Hopkins University Applied Physics Laboratory, Laurel, Maryland, USA.
Carolyn T FrommerJohns Hopkins University Applied Physics Laboratory, Laurel, Maryland, USA.
Alexander E ZambidisJohns Hopkins University Applied Physics Laboratory, Laurel, Maryland, USA.
Eric J SchneiderJohns Hopkins University Applied Physics Laboratory, Laurel, Maryland, USA.
Martina Y ZhaoJohns Hopkins University Applied Physics Laboratory, Laurel, Maryland, USA.
Benny K MugoJohns Hopkins University Applied Physics Laboratory, Laurel, Maryland, USA.
William ClarkeJohns Hopkins Medicine, Baltimore, Maryland, USA.
Kate KruczynskiJohns Hopkins Environmental Health Microbiology and Immunology Laboratory (JH-EHMIL), Bloomberg School of Public Health, Baltimore, Maryland, USA.
Nora PisanicJohns Hopkins Environmental Health Microbiology and Immunology Laboratory (JH-EHMIL), Bloomberg School of Public Health, Baltimore, Maryland, USA.
Christopher D HeaneyJohns Hopkins Environmental Health Microbiology and Immunology Laboratory (JH-EHMIL), Bloomberg School of Public Health, Baltimore, Maryland, USA.ORCID 0000-0003-3211-8495
Teresa A ColellaJohns Hopkins University Applied Physics Laboratory, Laurel, Maryland, USA.ORCID 0009-0009-1190-0024

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of the study was to estimate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence in the Howard County, Maryland, general population and demographic subpopulations attributable to natural infection or coronavirus disease 2019 (COVID-19) vaccination and to identify self-reported social behaviors that may affect the likelihood of recent or past SARS-CoV-2 infection. A cross-sectional, saliva-based serological study of 2,880 residents of Howard County, Maryland, was carried out from July through September 2021. Natural SARS-CoV-2 infection prevalence was estimated by inferring infections among individuals according to anti-nucleocapsid immunoglobin G levels and calculating averages weighted by sample proportions of various demographics. Antibody levels between BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) recipients were compared. Antibody decay rate was calculated by fitting exponential decay curves to cross-sectional indirect immunoassay data. Regression analysis was carried out to identify demographic factors, social behaviors, and attitudes that may be linked to an increased likelihood of natural infection. The estimated overall prevalence of natural infection in Howard County, Maryland, was 11.9% (95% confidence interval, 9.2% to 15.1%), compared with 7% reported COVID-19 cases. Antibody prevalence indicating natural infection was highest among Hispanic and non-Hispanic Black participants and lowest among non-Hispanic White and non-Hispanic Asian participants. Participants from census tracts with lower average household income also had higher natural infection rates. After accounting for multiple comparisons and correlations between participants, none of the behavior or attitude factors had significant effects on natural infection. At the same time, recipients of the mRNA-1273 vaccine had higher antibody levels than those of BNT162b2 vaccine recipients. Older study participants had overall lower antibody levels compared with younger study participants. The true prevalence of SARS-CoV-2 infection is higher than the number of reported COVID-19 cases in Howard County, Maryland. A disproportionate impact of infection-induced SARS-CoV-2 positivity was observed across different ethnic/racial subpopulations and incomes, and differences in antibody levels across different demographics were identified. Taken together, this information may inform public health policy to protect vulnerable populations.

Indexed as

COVID-19COVID-19 Vaccines2019-nCoV Vaccine mRNA-1273Antibodies, ViralBNT162 VaccineCross-Sectional StudiesHumansImmunoglobulin GMarylandPrevalenceSalivaSARS-CoV-2Seroepidemiologic Studies2019-nCoV Vaccine mRNA-1273Antibodies, ViralBNT162 VaccineCOVID-19 VaccinesImmunoglobulin Gantibody decay rateBNT162b2community health studyHoward CountyMarylandmRNA-1273oral fluid SARS-CoV-2 IgG assaySARS-CoV-2seroprevalence

Identifiers

PMID37289070
PMCPMC10433989

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.